Cytokine Storm
📧 Sign up to get email alerts when something new happens for Cytokine Storm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: UNITE Study (UMN-GE) for COVID-19 [NA]
The UNITE study (UMN-GE) for COVID-19 with cytokine storm is reported as completed; no results are provided in the document.
-
CLINICAL_TRIALS trial_result · 2023-08-24Clinical Trial Update: Early Treatment of Cytokine Storm Syndrome in Covid-19 [Phase 3]
Phase 3 trial of early treatment for cytokine storm in COVID-19 has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-08-22Clinical Trial Update: Asses the Anti-inflammatory Effects of Short Term Copaxone Therapy on Patients the Acute Decompensated Heart Failure [Phase 2]
Phase 2 clinical trial update evaluating short-term Copaxone therapy for anti-inflammatory effects in acute decompensated heart failure.
-
CLINICAL_TRIALS trial_result · 2021-09-02Clinical Trial Update: Menstrual Blood Stem Cells in Severe Covid-19 [Phase 1, Phase 2]
A Phase 1/2 trial investigating menstrual blood–derived stem cells for severe COVID-19 with cytokine storm has completed.
-
CLINICAL_TRIALS trial_result · 2021-08-19Clinical Trial Update: Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients [Phase 2]
Phase 2 exploratory trial evaluating basiliximab for pulmonary cytokine storm in hospitalized adults with SARS-CoV-2 infection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-24Clinical Trial Update: Treatment of Severe COVID-19 Patients Using Secretome of Hypoxia-Mesenchymal Stem Cells in Indonesia [Phase 2]
A Phase 2 clinical trial in Indonesia evaluating secretome from hypoxia-conditioned mesenchymal stem cells for severe COVID-19 with cytokine…
-
CLINICAL_TRIALS trial_result · 2021-02-17Clinical Trial Update: Intramuscular Effect of Polymerized Type I Collagen on the Cytokine Storm in COVID-19 Patients [Phase 1, Phase 2]
Early-phase trial exploring intramuscular polymerized type I collagen for modulation of cytokine storm in COVID-19 patients with inflammator…
-
CLINICAL_TRIALS trial_result · 2020-07-13Clinical Trial Update: To Determine the Efficacy of Neurokinin 1 Receptor Antagonist as a Therapeutic Tool Against Cytokine Storm and Respiratory Failure in Covid-19 Patients [Phase 3]
A Phase 3 clinical trial is investigating a neurokinin-1 receptor antagonist as a therapy for cytokine storm and respiratory failure in COVI…